Implantable cardioverter defibrillators: therapy against Canada's leading killer

Tang, Anthony S. L.
October 2004
CMAJ: Canadian Medical Association Journal;10/26/2004, Vol. 171 Issue 9, p1037
Academic Journal
Discusses the use of implantable cardioverter defibrillators (ICD) for the prevention of sudden cardiac deaths in Canada. Developments in the therapeutic device since 1980; Functions of pulse generators; Mechanism of ICDs; Patients who may benefit from ICD therapy.


Related Articles

  • Sudden cardiac death: opportunities for prevention. Morgan, J. M.; Cowan, J. C.; Camm, A. J.; McComb, J. M. // Heart;Jun2006, Vol. 92 Issue 6, p721 

    The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current...

  • Monitoring an unstable heart.  // Mayo Clinic Health Letter;Jun2006, Vol. 24 Issue 6, p1 

    Offers information on the use of an implantable cardioverter-defibrillator (ICD) to help prevent death from sudden cardiac arrest by quickly calming a chaotic heart. Description of two heart rhythm disorders; Individuals in which an ICD serves to be the most effective therapy to prevent sudden...

  • Boston Scientific gets CE mark for Confient ICD to treat SCD.  // Medical Device Daily;10/12/2007, Vol. 11 Issue 196, p1 

    The article reports that Boston Scientific's Confient implantable cardioverter-defibrillator (ICD), a cardiac rhythm management device to treat sudden cardiac death (SCD), has received the CE-mark approval. The device has an AV Search Hysteresis feature designed to reduce unnecessary right...

  • Implantable Defibrillators Reduce Death By 23% in Landmark Heart Failure Trial: NIH Study Indicates Need to More Aggressively Identify and Protect Patients at Risk for SCA.  // Journal of Cardiovascular Management;May/Jun2004, Vol. 15 Issue 3, p28 

    Reports on the results of the clinical trial for the implantable cardioverter-defibrillator therapy in people with heart failure in the U.S. Efficacy of the treatment in preventing sudden cardiac death; Safety profile in terms of general adverse events; Reason behind the underutilization of the...

  • Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation. Lopera, Gustavo; Beathard, Gerald; Exaire, Jose; Carrillo, Roger // Journal of Interventional Cardiac Electrophysiology;Jun2012, Vol. 34 Issue 1, p101 

    The article offers recommendations for the use of implantable cardioverter-defibrillator (ICD) therapy for primary and secondary prevention of sudden cardiac death (SCD) in end-stage renal disease (ESRD) patients. It suggests offering epicardial or subcutaneous cardiac implantable electronic...

  • Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? González-Enríquez, S.; Rodríguez-Entem, F.; Expósito, V.; Castrillo-Bustamante, C.; Canteli, A.; Solloso, A.; Madrazo, I.; Olalla, J. // Journal of Interventional Cardiac Electrophysiology;Dec2012, Vol. 35 Issue 3, p343 

    Background: It is now well established that implantable cardioverter defibrillator (ICD) implantation reduces mortality in patients at increased risk of sudden cardiac death. However, the best programming parameters remain controversial. Our traditional policy has followed a simple approach in...

  • Study: 'real value outcomes, cost data involved in ICD use. Stommen, Jim // Medical Device Daily;5/7/2008, Vol. 12 Issue 89, p1 

    The article discusses research being done on the cost of implantable cardioverter defibrillators (ICD) for prevention of sudden cardiac arrest (SCA) and death in elderly patients. It references a study by Peter Groeneveld et al, published in the April 2007 issue of "Heart Rhythm." The...

  • Implantable cardioverter defibrillators work -- so why aren't we using them? Simpson, Christopher S. // CMAJ: Canadian Medical Association Journal Supplement;7/3/2007, Vol. 177 Issue 1, p49 

    The author comments on a study on implantable cardioverter defibrillators, a device used to reduce the death rate among survivors of cardiac arrest, conducted by D. H. Birnie and colleagues. The authors of the study found that the implantation rate of the device into survivors of sudden cardiac...

  • Cameron Health Completes Enrollment in Pivotal FDA Clinical Study of the SICD( r) System.  // Biomedical Market Newsletter;5/9/2011, p507 

    The article reports that Cameron Health Inc. has completed enrollment in its pivotal FDA (U.S. Food & Drug Administration) clinical study of completely subcutaneous implantable defibrillator S-ICD System. Under the study, 330 patients were enrolled who were at risk for sudden cardiac arrest...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics